(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
 . . . . . . . . . .



Announcing the 2nd Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa [1]

[]

Date: 2024-06-25  

WHO’s Local Production and Assistance Unit, together with the Africa Centres for Disease Control and Prevention, and the Directorate-General for International Partnerships of the European Commission, are the co-organizers of the 2nd edition of the "Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa." This pivotal event will take place from June 25 to 27, 2024, in Nairobi, Kenya.

Building on the successes and insights gained from the inaugural event in 2023, this year's edition aims to promote increased private sector engagement and opportunities. It will convene African and international pharmaceutical and vaccine manufacturers, development financial institutions, and international organizations to strengthen partnerships and foster new collaborations. With Africa's pharmaceutical market poised for significant growth, this event is critical for promoting opportunities for the private sector and advancing local manufacturing capabilities and reducing dependency on imported vaccines and pharmaceuticals.

The event will provide extensive private sector networking and engagement opportunities, enabling participants to strengthen existing partnerships and forge new collaborations between global and Africa-based vaccine and pharmaceutical manufacturers. This will facilitate technology partnerships and boost investments for local pharmaceutical and vaccine production.

Participants will learn about market access and off-take mechanisms such as the African Vaccine Manufacturing Accelerator by GAVI and African pooled procurement mechanisms. The event will also offer a platform to examine sustainable business models, technologies, and investment partnerships crucial for vaccine and pharmaceutical manufacturing in Africa. Additionally, attendees from the private sector will gain a comprehensive understanding of available financial and technical support programs and how to access them. The supply chain segment will allow engagement with technology providers and supply chain actors essential for pharmaceutical and vaccine manufacturing.

The event is designed to benefit a wide range of stakeholders, including:

African pharmaceutical companies and startups;

LMIC and global pharmaceutical companies; and,

Technology providers

Alongside

International finance institutions such as the African Development Bank and International Finance Corporation;

Development partners such as GAVI the Vaccine Alliance, the Global Fund, Unitaid; and

Industry partners: African Vaccine Manufacturing Initiative (AVMI), Developing Countries Vaccine Manufacturers Network (DCVMN), Federation of African Pharmaceutical Manufacturers Associations (FAPMA), and International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

The event is organized with financial support by the German Federal Ministry for Economic Cooperation and Development (BMZ).

Register now: If you are interested in attending, please register here. On a first-come, first-served basis, this event will be for in-person attendance only.

Join us in Nairobi for this event and be a part of shaping the future of sustainable vaccine and pharmaceutical manufacturing in Africa.

For more information, please contact localproduction@who.int.

[END]
---
[1] Url: https://www.who.int/news-room/events/detail/2024/06/25/default-calendar/announcing-the-2nd-global-event-on-harnessing-private-sector-engagement-for-sustainable-vaccine-and-pharmaceutical-manufacturing-in-africa

Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/